These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9568591)

  • 1. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
    Ross JA; Leavitt SA
    Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver.
    Leavitt SA; DeAngelo AB; George MH; Ross JA
    Carcinogenesis; 1997 Nov; 18(11):2101-6. PubMed ID: 9395208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
    Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
    Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
    Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
    Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
    Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
    Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
    Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
    Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
    Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats.
    Chen T; Mittelstaedt RA; Aidoo A; Hamilton LP; Beland FA; Casciano DA; Heflich RH
    Environ Mol Mutagen; 2001; 37(3):195-202. PubMed ID: 11317337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene- and tissue-specificity of mutation in Big Blue rats treated with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene.
    Chen T; Mittelstaedt RA; Shelton SD; Dass SB; Manjanatha MG; Casciano DA; Heflich RH
    Environ Mol Mutagen; 2001; 37(3):203-14. PubMed ID: 11317338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
    Shane BS; Lockhart AM; Winston GW; Tindall KR
    Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
    Davies R; Gant TW; Smith LL; Styles JA
    Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ; Provost GS; Young RR; Putman DL; Short JM
    Mutat Res; 1995 Mar; 327(1-2):57-66. PubMed ID: 7870099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.